Shanxi Jinbo Biomedical Technology Co., Ltd.

As a national-level "specialized, refined, special, and new" (SRSN) small and medium-sized enterprise, Shanxi Jinbo Biomedical Technology Co., Ltd. is the "chain leader" of Shanxi's synthetic biotechnology industry chain. It is the standard setter for the medical device industry of original innovative recombinant human collagen medical materials, and has been granted 50 invention patents, including 3 international invention patents. Focusing on human structural materials and major human infectious diseases, the company has achieved breakthroughs in a number of original innovative achievements. By employing cutting-edge technologies in structural biology and synthetic biology, it has become the world's first enterprise to achieve large-scale green manufacturing of advanced triple helix structure "Type A Recombinant Human Collagen". In the field of major human infectious diseases, by employing the theory of virus entry inhibition, it has achieved the industrialization and terminal product development of broad-spectrum anti-HPV bioproducts and broad-spectrum anti-coronavirus peptide drugs for the first time.

Products in Display:  "Weiyimei" Type A recombinant human collagen and other recombinant Type III human collagen freeze-dried fiber products; "ProtYouth" collagen products; "Zhongyuan" collagen products; "Jinbo" anti-HPV bioproduct dressing, etc.